Cargando…
Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern
Detection of secretory antibodies in the airway is highly desirable when evaluating mucosal protection by a vaccine against a respiratory virus like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We show that a single intranasal delivery of an attenuated SARS-CoV-2 (Nsp1-K164A/H16...
Autores principales: | Wang, Tony, Stauft, Charles, Selvaraj, Prabhuanand, D'agnillo, Felice, Meseda, Clement, Sangare, Kotou, Pedro, Cyntia, Liu, Shufeng, Lien, Christopher, Weir, Jerry, Starost, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665342/ https://www.ncbi.nlm.nih.gov/pubmed/36380761 http://dx.doi.org/10.21203/rs.3.rs-2227555/v1 |
Ejemplares similares
-
Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants
por: Stauft, Charles B., et al.
Publicado: (2023) -
Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
por: Liu, Shufeng, et al.
Publicado: (2022) -
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
por: Meseda, Clement A., et al.
Publicado: (2021) -
SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity
por: Nuñez, Ivette A., et al.
Publicado: (2021) -
SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection
por: Nuñez, Ivette A., et al.
Publicado: (2021)